Effects of mTOR inhibitor everolimus (RAD001) on bladder cancer cells

Effects of mTOR inhibitor everolimus (RAD001) on bladder cancer cells

10.1158/1078-0432.CCR-09-3202

Saved in:

Bibliographic Details
Main Authors:	Chiong, E., Lee, I.-L., Dadbin, A., Sabichi, A.L., Harris, L., Urbauer, D., McConkey, D.J., Dickstein, R.J., Cheng, T., Grossman, H.B.
Other Authors:	SURGERY
Format:	Article
Published:	2016
Online Access:	http://scholarbank.nus.edu.sg/handle/10635/125687
Tags:	Add Tag No Tags, Be the first to tag this record!
Institution:	National University of Singapore

Similar Items

mTOR, autophagy, and reprogramming
by: Tang, B.L
Published: (2020)

Role of mTOR inhibitor in cholangiocarcinoma cell progression
by: Penpak Moolthiya, et al.
Published: (2018)

An in vitro assay for the kinase activity of mTOR complex 2
by: Huang, J.
Published: (2016)

Flcn-deficient renal cells are tumorigenic and sensitive to mTOR suppression
by: Wu, M, et al.
Published: (2020)

mTOR as a potential therapeutic target for treatment of keloids and excessive scars
by: Ong, C.T., et al.
Published: (2011)

MTOR modulation induces selective perturbations in histone methylation which influence the anti-proliferative effects of mTOR inhibitors
by: Kim, HaEun, et al.
Published: (2024)

Judicious toggling of mTOR activity to combat insulin resistance and cancer: Current evidence and perspectives
by: Ong, P.S, et al.
Published: (2020)

mTOR complex 2 targets Akt for proteasomal degradation via phosphorylation at the hydrophobic motif
by: Wu, Y.-T., et al.
Published: (2014)

Molecular mechanisms of tumor resistance to PI3K-mTOR-targeted therapy
by: Tan, J., et al.
Published: (2014)

PI3K/AKT/mTOR signaling transduction pathway and targeted therapies in cancer
by: Glaviano, A, et al.
Published: (2023)

28S rRNA is inducibly pseudouridylated by the mTOR pathway translational control in CHO cell cultures
by: Courtes, F.C., et al.
Published: (2014)

Transcriptomic Repositioning Analysis Identifies mTOR Inhibitor as Potential Therapy for Epidermolysis Bullosa Simplex
by: Gun Ho Lee, et al.
Published: (2022)

Transcriptomic Repositioning Analysis Identifies mTOR Inhibitor as Potential Therapy for Epidermolysis Bullosa Simplex
by: Lee G.H.
Published: (2023)

Diallyl disulfide induces apoptosis and autophagy via mTOR pathway in myeloid leukemic cell line
by: Tanitta Suangtamai, et al.
Published: (2018)

Acquired resistance to PI3K/mTOR inhibition is associated with mitochondrial DNA mutation and glycolysis
by: Koh K.X., et al.
Published: (2020)

Molecular rationale for the use of PI3K/AKT/mTOR pathway inhibitors in combination with crizotinib in ALK-mutated neuroblastoma
by: Moore, N.F, et al.
Published: (2020)

Activation of the PI3K-Akt-mTOR signaling pathway promotes necrotic cell death via suppression of autophagy
by: Wu, Y.-T., et al.
Published: (2011)

Antifungal drug itraconazole targets VDAC1 to modulate the AMPK/mTOR signaling axis in endothelial cells
by: Head, Sarah A., et al.
Published: (2016)

Growth hormone increases BDNF and mTOR expression in specific brain regions after photothrombotic stroke in mice
by: Sanchez-Bezanilla, Sonia, et al.
Published: (2023)

VS-5584, a novel and highly selective PI3K/mTOR kinase inhibitor for the treatment of cancer
by: Hart, S., et al.
Published: (2016)

Microalga Chlorella sp. extract induced apoptotic cell death of cholangiocarcinoma via AKT/mTOR signaling pathway
by: Sawasdee N.
Published: (2023)

Microalga Chlorella sp. extract induced apoptotic cell death of cholangiocarcinoma via AKT/mTOR signaling pathway
by: Sawasdee N.
Published: (2023)

Microalga Chlorella sp. extract induced apoptotic cell death of cholangiocarcinoma via AKT/mTOR signaling pathway
by: Sawasdee N.
Published: (2023)

Casticin-induced inhibition of cell growth and survival are mediated through the dual modulation of Akt/mTOR signaling cascade
by: Lee, J.H., et al.
Published: (2022)

Trisubstituted-imidazoles induce apoptosis in human breast cancer cells by targeting the oncogenic PI3K/Akt/mTOR signaling pathway
by: Mohan C.D., et al.
Published: (2018)

Suppression of PI3K/Akt/mTOR pathway in chrysoeriol-induced apoptosis of rat C6 glioma cells
by: Suppanut Wongkularb, et al.
Published: (2022)

Melatonin attenuates cisplatin-induced HepG2 cell death via the regulation of mTOR and ERCC1 expressions
by: Kangsadarn Bennukul, et al.
Published: (2018)

Suppression of PI3K/Akt/mTOR pathway in chrysoeriol-induced apoptosis of rat C6 glioma cells
by: Wongkularb S.
Published: (2023)

Impaired autophagy due to constitutive mTOR activation sensitizes TSC2-null cells to cell death under stress
by: Ng, S., et al.
Published: (2014)

SAHA and cisplatin sensitize gastric cancer cells to doxorubicin by induction of DNA damage, apoptosis and perturbation of AMPK-mTOR signalling
by: Seah, Kwi Shan, et al.
Published: (2023)

Induction of autophagy by palmitic acid via protein kinase C-mediated signaling pathway independent of mTOR (mammalian target of rapamycin)
by: Tan, S.H., et al.
Published: (2014)

?-tocotrienol inhibits angiogenesis-dependent growth of human hepatocellular carcinoma through abrogation of AKT/mTOR pathway in an orthotopic mouse model
by: Siveen K.S., et al.
Published: (2020)

Brassinin represses invasive potential of lung carcinoma cells through deactivation of PI3K/Akt/mTOR signaling cascade
by: Yang, M.H., et al.
Published: (2021)

Hypaphorine attenuates lipopolysaccharide-induced endothelial inflammation via regulation of TLR4 and PPAR-γ dependent on PI3K/Akt/mTOR signal pathway
by: Sun, H, et al.
Published: (2020)

TIPE2 induced the proliferation, survival, and migration of lung cancer cells through modulation of AKt/mTOR/NF-κB signaling cascade
by: Bordoloi, D., et al.
Published: (2021)

γ-tocotrienol inhibits angiogenesis-dependent growth of human hepatocellular carcinoma through abrogation of AKT/mTOR pathway in an orthotopic mouse model
by: Siveen, K.S., et al.
Published: (2014)

PDK1 signaling toward PLK1-MYC activation confers oncogenic transformation, tumor-initiating cell activation, and resistance to mTOR-targeted therapy
by: Tan, J., et al.
Published: (2014)

PI3 K/Akt/mTOR-mediated translational control regulates proliferation and differentiation of lineage-restricted RoSH stem cell lines
by: Que, J., et al.
Published: (2011)

A loss-of-function genetic screening reveals synergistic targeting of AKT/mTOR and WTN/β-catenin pathways for treatment of AML with high PRL-3 phosphatase
by: Zhou, J, et al.
Published: (2020)

PRIMA-1<sup>met</sup> induces autophagy in colorectal cancer cells through upregulation of the mTOR/AMPK-ULK1-Vps34 signaling cascade
by: Li, XL, et al.
Published: (2021)